...
机译:假定的癌症干细胞标志物ABCB1,ABCG2和CD133的表达与胃癌的分化程度相关
Department of Pathology, Harbin Medical University, 157 Xuefu Road, Nangang District, Harbin, 150081, Heilongjiang, People’s Republic of China;
Department of Pathology, Harbin Medical University, 157 Xuefu Road, Nangang District, Harbin, 150081, Heilongjiang, People’s Republic of China;
Department of Gastroenterology of the Second Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China;
Department of Pathology, Harbin Medical University, 157 Xuefu Road, Nangang District, Harbin, 150081, Heilongjiang, People’s Republic of China;
Department of Pathology, Harbin Medical University, 157 Xuefu Road, Nangang District, Harbin, 150081, Heilongjiang, People’s Republic of China;
Department of Pathology, Harbin Medical University, 157 Xuefu Road, Nangang District, Harbin, 150081, Heilongjiang, People’s Republic of China;
Department of Pathology, Harbin Medical University, 1;
Cancer stem cell marker; Gastric cancer; Differentiation;
机译:假定的癌干细胞标志物ABCB1,ABCG2和CD133的表达与胃癌的分化程度相关
机译:眼睑皮脂腺癌中的癌症干细胞标志物:ALDH1,CD133和ABCG2的高表达与不良预后相关
机译:眼睑皮脂腺癌中的癌症干细胞标志物:ALDH1,CD133和ABCG2的高表达与不良预后相关
机译:干细胞样标志物CD133或CD24在胃癌循环肿瘤细胞不同亚群中的表达及临床意义的试验研究
机译:尼洛替尼(TasignaRTM)在癌症化疗中调节ABCB1 / PGP和ABCG2 / BCRP介导的多药耐药性。
机译:假定的癌症干细胞标志物CD133CD166CD44sEpCAM和ALDH1的表达对结直肠癌的预后影响
机译:推定癌症干细胞标记物ABCB1,ABCG2和CD133的表达与胃癌的分化程度相关